Pediatrics

Early Clinical Trial Data Show Gene Therapy Reversing Sickle Cell Anemia



Newswise imageAfter over a decade of preclinical research and development, a new gene therapy treatment for Sickle Cell Anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.

Source link

Related posts

Eggs and Heart Disease; ADHD and Psychosis: It's PodMed Double T! (with audio)

Newsemia

High-Versus Low-Dose Aspirin in the Treatment of Kawasaki Disease

Newsemia

Breast Abscess Sequelae

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World